Breast Cancer Risk Increased With Weight Gain After Age 35 Years
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 18, 2024 -- The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology & Medicine.
Katherine De la Torre, from the Seoul National University College of Medicine in South Korea, and colleagues conducted a prospective study to examine the association between weight change throughout distinct lifetime periods and breast cancer risk stratified by menopausal status. A total of 73,192 Korean women (aged 40 to 69 years) were prospectively followed during a median follow-up of 9.2 years.
The researchers found 790 new breast cancer cases among 66,870 women with information on weight at 35 years of age. Of these women, 10.72, 32.68, and 35.92 percent had weight loss, maintained stable weight, and gained >5.0 kg, respectively. Compared with women with stable weight, those who gained >10 kg after 35 years of age had an increased risk for breast cancer (hazard ratio, 1.41). Among premenopausal women, gaining 5 to 9.9 kg and ≥10 kg after 35 years of age increased the risk for breast cancer (hazard ratios, 1.89 and 2.23, respectively), with a dose-response effect. Women who gained >0.75 kg per year after age 35 years had an increased risk for breast cancer when a linear weight increment was assumed (hazard ratio, 1.35), but there were no associations based on menopausal status.
"Our research points to the critical period after age 35 as a potential window for weight management interventions aimed at breast cancer prevention," lead author Daehee Kang, M.D., Ph.D., also from Seoul National University Hospital, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
WEDNESDAY, May 28, 2025 -- For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related...
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
Post-Kidney Transplant Adverse Outcomes Increased With BMI-BSA Obesity
TUESDAY, May 27, 2025 -- Combined body mass index (BMI)-body surface area (BSA) obesity is associated with an increased risk for post-kidney transplant (KT) adverse outcomes...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.